Microbiome diversity has been associated with improved outcomes after allogeneic stem-cell transplantation in patients with hematological cancers. Multimodal analysis of intestinal microbiome and metabolome data helped identify immunomodulatory microbial metabolites that were predictive of survival, transplant-related mortality and cancer relapse. These metabolites were products of short-chain-fatty-acid-synthesis pathways, and their associated genes were expressed by both bacterial species and bacteriophages.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs43018-023-00670-4/MediaObjects/43018_2023_670_Fig1_HTML.png)
References
Peled, J. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Eng. J. Med. 382, 822–834 (2020). This is an analysis of an international cohort that linked human microbiome to overall survival and transplantation-related mortality in allo-SCT.
Swimm, A. et al. lndoles derived from intestinal microbiota act via type I interferon signalling to limit graft-versus-host disease. Blood 132, 2506–2519 (2018). This paper reports that microbiota-derived indole-3-carboxaldehyde provides protection against GvHD in mouse models of allo-SCT.
Argelaguet, R. et al. Multi-Omics Factor Analysis — a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, e8124 (2018). This paper describes the MOFA framework for the integration of multi-omics datasets and identification of shared features.
Fischer, J. C. et al. RIG-I/MAVS and STING signalling promote gut integrity during irradiation and immune-mediated tissue injury. Sci. Transl. Med. 9, eaag2513 (2017). This paper shows that activators of type I interferon signaling can positively or negatively modulate GvHD, depending on timing.
Michonneau, D. et al. Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites. Nat. Commun. 10, 5695 (2019). This paper was the first to perform a comprehensive untargeted analysis of the metabolome in the blood of patients receiving allo-SCT.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Thiele Orberg, E. et al. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation. Nat. Cancer https://doi.org/10.1038/s43018-023-00669-x (2024).
Rights and permissions
About this article
Cite this article
Immunomodulatory microbial metabolites as potential predictors of stem-cell transplantation outcomes. Nat Cancer 5, 14–15 (2024). https://doi.org/10.1038/s43018-023-00670-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-023-00670-4